Analystreport

Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at Wedbush from $62.00 to $48.00.

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com